Scientists at UC San Francisco have developed a revolutionary cancer treatment that precisely targets tumors with radiation ...

The FDA makes furthering moves in SCLC, ovarian, and breast cancers, and the value of remote clinical pharmacists is explored in community oncology.

The first patient has been enrolled into the SOHO-02 trial, which will look at the drug’s potential as a first-line treatment for this type of lung cancer, comparing it to the current standard ...

Explore how T cell engagers could transform cancer and autoimmune treatments through promising trials and key collaborations.

The FDA has started a priority review of Amgen’s tarlatamab for small cell lung cancer (SCLC ... engager (BiTE) drugs for solid tumours. Tarlatamab is under review as a treatment for adult ...

Surgery is often the main treatment. Other treatments include: somatostatin analogues radiotherapy chemotherapy targeted cancer drugs Your treatment depends on what type of neuroendocrine cancer you ...

In a Phase Ib trial, 71 percent of patients responded to zongertinib and lived a median six months before disease progression or death.

Even everyday stress, the kind that many people experience, impairs the cancer-fighting immune system.

21 Several drugs used for the treatment of ileal and colonic IBD have been formulated ... Pharmacokinetic studies of new pH dependent formulations of other drugs targeted at the distal ileum and colon ...

Imagine being able to get a faster diagnosis of a condition based on your unique situation, be given personalised treatments based on what would be most effective for you and experience fewer, if any, ...